Predict your next investment

ELECTRONICS | Chips & Semiconductors / Semiconductors
noblepeak.com

See what CB Insights has to offer

Founded Year

2002

Stage

Series C | Alive

Total Raised

$22M

Last Raised

$2M | 12 yrs ago

About NoblePeak Vision

NoblePeak designs and manufactures germanium-enhanced CMOS imager products that can extend camera sensitivity from the visible through the Short Wave Infrared spectrum on a single low-cost silicon chip, offering day-through-night vision performance with applications in the commercial security and military markets.

NoblePeak Vision Headquarter Location

500 Edgewater Drive

Wakefield, Massachusetts, 01880,

United States

781-224-9740

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NoblePeak Vision Patents

NoblePeak Vision has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/13/2004

1/5/2010

Optical devices, Sensors, Photonics, Optical communications, Fiber optics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/13/2004

00/00/0000

00/00/0000

Grant Date

1/5/2010

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Optical devices, Sensors, Photonics, Optical communications, Fiber optics

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.